Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
INVESTOR'S BUSINESS DAILY

Archrock Receives IBD Stock Rating Upgrade

The IBD SmartSelect Composite Rating for Archrock rose from 93 to 97 Tuesday.

The new score indicates the company is now outperforming 97% of all stocks in terms of the most important fundamental and technical stock-picking criteria. The market's biggest winners often have a 95 or higher rating in the early stages of a new price run, so that's an important benchmark to look for when looking for the best stocks to buy and watch.

Archrock has now climbed above a proper buy zone after clearing the 21.87 entry in a cup with handle.

Looking For The Best Stocks To Buy And Watch? Start Here

The stock sports a 99 EPS Rating, meaning its recent quarterly and annual earnings growth tops 99% of all stocks.

Its Accumulation/Distribution Rating of D shows moderate selling by institutional investors over the last 13 weeks. Look for the rating to improve to at least a C or better.

In Q4, the company reported 67% earnings-per-share growth. Top line growth increased 26%, up from 15% in the prior report. That marks two consecutive reports with rising growth.

Archrock holds the No. 1 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. Baker Hughes and DNOW are also among the group's highest-rated stocks.

This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.